-
Sanofi, GSK Can't Escape Zantac Proposed Class Actions, Judge Rules Opens in a new window)
The lawsuits are part of the broader multidistrict litigation over Zantac and ranitidine after various drugmakers including the defendants launched recalls of their products in 2019. -
'Entirely Unsurprising': Merck Slammed for 4,000% Markup of Taxpayer-Funded COVID-19 Drug Opens in a new window)
"Another example of Big Pharma reaping billions from public investment into research".Comments
-
AbbVie Loses a Lawsuit Over Humira Trade Secrets it Claimed Were Stolen Opens in a new window)
A U.S. federal court judge dismissed a lawsuit in which the drug maker claimed a would-be rival hired one of its employees, who then allegedly transferred a boatload of confidential information about its best-selling Humira treatment.Comments
-
Government Price Controls Will Kill Pharma Innovation, Lilly CEO Says Opens in a new window)
America is the cradle of breakthrough pharmaceutical innovation. U.S. biopharmaceutical companies create nearly two in every three new medicines.Comments
-
Buyers Clamor for Merck's COVID-19 Antiviral Molnupiravir, but Pricing is Already Controversial Opens in a new window)
Less than a week after Merck and Ridgeback released extraordinary data on the effectiveness of experimental COVID-19 drug molnupiravir, the rush is on to lock up supplies.Comments
-
‘Pharma Bro’ Review: Behind the Smirk Opens in a new window)
This documentary grasps at straws trying to prove that the former pharmaceutical executive Martin Shkreli might not be as loathsome as his reputation suggests.Comments
-
Merck Sells Federally Financed Covid Pill to U.S. for 40 Times What it Costs to Make Opens in a new window)
The Covid-19 treatment molnupiravir was developed using funding from the National Institutes of Health and the Department of Defense.Comments
-
Eli Lilly CEO: Drug Pricing Bill Would 'Fundamentally Restructure' Company
Eli Lilly CEO David Ricks joins CNBC's Meg Tirrell to discuss how a pending drug pricing bill would "fundamentally restructure" the company's business model.Comments
-
DOJ Says Three Generic Drug Companies Resolve Price-Fixing Allegations Opens in a new window)
The Justice Department said these conspiracies allegedly resulted in higher drug prices for federal healthcare programs and beneficiaries according.Comments
-
Three Generic Drug Makers to Pay $450 Million to Settle Civil Price Fixing Charges Opens in a new window)
In each instance, the companies — the Sandoz unit at Novartis, Taro Pharmaceuticals and Apotex — admitted to working with rivals to set prices and supplies, and allocate customers for different medicines between 2013 and 2015.Comments
-
The U.S. Can Lower Drug Prices Without Sacrificing Innovation Opens in a new window)
Large pharmaceutical companies are nowhere near as important to real drug innovation as they purport to be.Comments
-
Merck’s New Covid-19 Drug Could be One of the Most Lucrative Drugs Ever Opens in a new window)
The drug, named molnupiravir, reduces the risk of hospitalization or death by 50% in Covid-19 patients with mild and moderate symptoms compared with placebo, Merck said.Comments
-
Nonprofit Linked to PhRMA Behind Ads Opposing Drug Pricing Changes Opens in a new window)
Undisclosed in the heart-wrenching commercials: The Partnership to Fight Chronic Disease has extensive ties to the lobby for major pharmaceutical companies, the Pharmaceutical Research and Manufacturers of America, or PhRMA.Comments
-
Drug Companies Are Still Under Scrutiny For Drug Price Gouging Opens in a new window)
The pharma industry has struggled for years with a poor reputation due to high drug prices and unethical business practices.Comments
-
Lilly to Cut Price of Lispro Insulin Injection by 40% From Jan. 1 Opens in a new window)
The move would bring down the price of Insulin Lispro Injection to $82.41 for individual vials and $159.12 for a pack of five pens.Comments
Comments